ALZN - Alzamend Neuro, Inc.
1.98
0.030 1.515%
Share volume: 29,977
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$1.95
0.03
0.02%
Summary score
35%
Profitability
35%
Dept financing
43%
Liquidity
49%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-128.54%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
146.87%
Debt ratio change over timeo
0%
Current Ratio
6.69%
Quick Ratio
0%
Cash Position Ratio
6.26%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-265.15%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
338.3%
Debt ratio change over timeo
0%
Current Ratio
1.15%
Quick Ratio
0%
Cash Position Ratio
0.97%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-635.89%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
510.74%
Debt ratio change over time
0%
Current Ratio
0.14%
Quick Ratio
0%
Cash Position Ratio
0.12%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ALZN | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 14.82% | 9.25% | 20.29% |
| Return on assets | -128.54% | 4.21% | 3.01% | 2.11% |
| Return on sales | 0% | 27.61% | 25.13% | 26.43% |
| Return on invested capital | 0% | 8.25% | 9.21% | 3.23% |
| Profitability | 0% | 91% | 77% | 70% |
| Total debt ratio | 146.87% | 81.46% | 59.72% | 91.54% |
| Debt ratio change over time | 0% | -9.8% | -49.67% | 745.88% |
| Dept financing | 25% | 14% | 10% | 41% |
| Current Ratio | 1.15% | 1.22% | 1.1% | 0.76% |
| Quick Ratio | 0% | 0.94% | 0.86% | 0.66% |
| Cash Position Ratio | 0.97% | 0.13% | 0.46% | 0.26% |
| Liquididy | 50% | 29% | 32% | 24% |
| Short-term ratios | ALZN | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -265.15% | 4.34% | 2.26% | 1% |
| Return on sales | 0% | 28.22% | 23.48% | 16.75% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 21% |
| Total debt ratio | 338.3% | 81.06% | 60.18% | 95.8% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 6% | 4% | 7% |
| Current Ratio | 1.15% | 1.22% | 1.1% | 0.76% |
| Quick Ratio | 0% | 0.94% | 0.86% | 0.66% |
| Cash Position Ratio | 0.97% | 0.13% | 0.46% | 0.26% |
| Liquididy | 49% | 53% | 57% | 40% |